Proteolytic patterns of head and neck squamous cell carcinoma

被引:10
作者
Schmidt, M [1 ]
Polednik, C [1 ]
Hoppe, F [1 ]
机构
[1] Univ Wurzburg, Dept Otorhinolaryngol, D-97080 Wurzburg, Germany
关键词
squamous cell carcinoma; head and neck neoplasms; tumor gelatinases; plasminogen activators; densitometry;
D O I
10.1007/s004050050161
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The significance of plasminogen activators and matrix metalloproteases for clinical outcome, growth and metastatic behavior of head and neck squamous cell carcinoma (SCC) is still controversial. The majority of studies has been based on either immunohistological stainings, which provide only limited quantitative information, or in vitro experiments. We analyzed 44 head and neck; SCC and 11 mucosa tissue samples for the expression of gelatinolytic or fibrinolytic proteases by quantitative zymographic analysis and compared lytic activities to clinical and histopathological data. We calculated activation ratios for matrix metalloproteinases-2 and -9 (MMP-2 and MMP-9) by separate evaluations of inactive and activated MMP forms. Increased gelatinolytic and fibrinolytic activity was found in head and neck SCC when compared to mucosa. Increased values were caused by MMP-9 and urokinase type plasminogen activator, respectively. No statistically significant correlations of either protease lytic activity or activation ratio could be related to T-stage, metastasis, tissue necrosis or the differentiation stage of tumors. The data recorded are compared with previously published reports.
引用
收藏
页码:346 / 350
页数:5
相关论文
共 22 条
[1]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[2]  
2-Z
[3]   PROTEOLYTIC REMODELING OF EXTRACELLULAR-MATRIX [J].
BIRKEDALHANSEN, H .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (05) :728-735
[4]   Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma [J].
Charous, SJ ;
Stricklin, GP ;
Nanney, LB ;
Netterville, JL ;
Burkey, BB .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1997, 106 (04) :271-278
[5]   REGULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY [J].
CLAYMAN, G ;
WANG, SW ;
NICOLSON, GL ;
ELNAGGAR, A ;
MAZAR, A ;
HENKIN, J ;
BLASI, F ;
GOEPFERT, H ;
BOYD, DD .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (01) :73-80
[6]   QUALITATIVE AND QUANTITATIVE DISTRIBUTION OF PLASMINOGEN ACTIVATORS IN ORGANS FROM HEALTHY ADULT MICE [J].
DANGLOT, G ;
VINSON, D ;
CHAPEVILLE, F .
FEBS LETTERS, 1986, 194 (01) :96-100
[7]  
DUFFY MJ, 1988, CANCER, V62, P531, DOI 10.1002/1097-0142(19880801)62:3<531::AID-CNCR2820620315>3.0.CO
[8]  
2-B
[9]   ELECTROPHORETIC ANALYSIS OF PLASMINOGEN ACTIVATORS IN POLYACRYLAMIDE GELS CONTAINING SODIUM DODECYL-SULFATE AND COPOLYMERIZED SUBSTRATES [J].
HEUSSEN, C ;
DOWDLE, EB .
ANALYTICAL BIOCHEMISTRY, 1980, 102 (01) :196-202
[10]  
Itaya T, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P197